Skip to main
MXL

MaxLinear (MXL) Stock Forecast & Price Target

MaxLinear (MXL) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 67%
Buy 0%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

MaxLinear is a strong investment opportunity with a Buy rating and a potential target price of $125, thanks to their partnership with a national laboratory, a 1.6T platform, and new product offerings. Despite some challenges, their recent revenue report showed higher than expected revenue and all segments are expected to grow, with infrastructure leading. This growth is expected to drive the target price up as their data center revenue increases with the help of their Keystone platform and Panther's storage accelerator SoC family.

Bears say

MaxLinear is poised for growth and benefit from the current restructuring, with a projected revenue of $657M in FY26, $805M in FY27, and $898M in FY28 and EPS growth of approximately 30%. However, the risk/reward may not be favorable as the company may not be able to reach its projected infrastructure mix and gross margin improvements, and its current valuation may not be justified by its P/E ratio compared to peers in the AI connectivity industry. Additionally, the company's growth may not be enough to justify its current stock price, posing a potential risk for investors.

MaxLinear (MXL) has been analyzed by 6 analysts, with a consensus rating of Buy. 67% of analysts recommend a Strong Buy, 0% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of MaxLinear and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About MaxLinear (MXL) Forecast

Analysts have given MaxLinear (MXL) a Buy based on their latest research and market trends.

According to 6 analysts, MaxLinear (MXL) has a Buy consensus rating as of Jul 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $68, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $68, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

MaxLinear (MXL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.